U.K. health insurance market is projected to register a CAGR of 4.7% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
Market Segmentation:
U.K. Health Insurance Market, By Type (Product, Solutions), Services (Inpatient Treatment, Outpatient Treatment, Medical Assistance, and Others), Level of Coverage (Bronze, Silver, Gold, and Platinum), Service Providers (Public Health Insurance Providers, Private Health Insurance Providers), Health Insurance Plans (Point of Service (POS), Exclusive Provider Organization (EPOS), Indemnity Health Insurance, Health Savings Account (HSA), Qualified Small Employer Health Reimbursement Arrangements (QSEHRAS), Preferred Provider Organization (PPO), Health Maintenance Organization (HMO), and Others), Demographics (Adults, Minors, and Senior Citizens), Coverage Type (Lifetime Coverage, Term Coverage), End User (Corporates, Individuals, and Others) Distribution Channel (Direct Sales, Financial Institutions, E-commerce, Hospitals, Clinics, and Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, Israel, South Africa, and Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Some of the major factors contributing to the growth of the market are:
Increasing cost of medical services
Growing number of daycare procedures
Market Players
Some of the major players operating in the U.K. health insurance market are:
Cigna
AVIVA
ALLIANZ CARE
AXA
BUPA
American International Group, Inc.
Vitality
FREEDOM HEALTH INSURANCE
Pru Life UK
SAGA
General and Medical Finance Ltd
Exeter Family Friendly
TABLE OF CONTENTS
1 INTRODUCTION 10
- 1.1 OBJECTIVES OF THE STUDY 10
- 1.2 MARKET DEFINITION 10
- 1.3 OVERVIEW OF U.K. HEALTH INSURANCE MARKET 10
- 1.4 LIMITATIONS 12
- 1.5 MARKETS COVERED 12
2 MARKET SEGMENTATION 14
- 2.1 MARKETS COVERED 14
- 2.2 GEOGRAPHICAL SCOPE 15
- 2.3 YEARS CONSIDERED FOR THE STUDY 15
- 2.4 CURRENCY AND PRICING 15
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL 16
- 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 19
- 2.7 DBMR MARKET POSITION GRID 20
- 2.8 MARKET END-USER COVERAGE GRID 21
- 2.9 DBMR MARKET CHALLENGE MATRIX 22
- 2.10 TYPE LIFE LINE CURVE 23
- 2.11 MULTIVARIATE MODELING 23
- 2.12 SECONDARY SOURCES 25
- 2.13 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 30
5 MARKET OVERVIEW 31
- 5.1 DRIVERS 33
- 5.1.1 INCREASING COST OF MEDICAL SERVICES 33
- 5.1.2 GROWING NUMBER OF DAYCARE PROCEDURES 34
- 5.1.3 MANDATORY PROVISION OF HEALTHCARE INSURANCE IN PUBLIC AND PRIVATE SECTORS 35
- 5.2 RESTRAINTS 36
- 5.2.1 HIGH COST OF INSURANCE PREMIUMS 36
- 5.2.2 STRICT DOCUMENTATION PROCESS FOR CLAIM REIMBURSEMENT 37
- 5.3 OPPORTUNITIES 38
- 5.3.1 ADVANTAGES OF HEALTH INSURANCE POLICIES 38
- 5.3.2 INCREASING HEALTHCARE EXPENDITURE 39
- 5.4 CHALLENGE 40
- 5.4.1 LACK OF AWARENESS REGARDING THE BENEFITS OF HEALTH INSURANCE 40
6 U.K. HEALTH INSURANCE MARKET, BY TYPE 41
- 6.1 OVERVIEW 42
- 6.2 PRODUCT 43
- 6.2.1 MEDICLAIM INSURANCE 44
- 6.2.2 INDIVIDUAL COVERAGE INSURANCE 44
- 6.2.3 FAMILY FLOATER COVERAGE INSURANCE 44
- 6.2.4 HOSPITALIZATION COVERAGE INSURANCE 44
- 6.2.5 SENIOR CITIZEN COVERAGE INSURANCE 44
- 6.2.6 CRITICAL ILLNESS INSURANCE 44
- 6.2.7 UNIT LINKED HEALTH PLANS 44
- 6.2.8 PERMANENT HEALTH INSURANCE 44
- 6.3 SOLUTIONS 44
- 6.3.1 LEAD GENERATIONS SOLUTIONS 45
- 6.3.2 REVENUE MANAGEMENT & BILLING SOLUTIONS 45
- 6.3.3 ROBOTIC PROCESS AUTOMATION 45
- 6.3.4 INSURANCE CLOUD SOLUTIONS 45
- 6.3.5 CLAIMS ADMINISTRATION CLOUD SOLUTIONS 45
- 6.3.6 VALUE-BASED PAYMENTS SOLUTIONS 45
- 6.3.7 ARTIFICIAL INTELLIGENCE & BLOCK CHAIN SOLUTIONS 46
- 6.3.8 INTELLIGENT CASE MANAGEMENT SOLUTIONS 46
- 6.3.9 OTHERS 46
7 U.K. HEALTH INSURANCE MARKET, BY SERVICES 47
- 7.1 OVERVIEW 48
- 7.2 INPATIENT TREATMENT 49
- 7.3 OUTPATIENT TREATMENT 49
- 7.4 MEDICAL ASSURANCE 50
- 7.5 OTHERS 50
8 U.K. HEALTH INSURANCE MARKET, BY LEVEL OF COVERAGE 51
- 8.1 OVERVIEW 52
- 8.2 BRONZE 53
- 8.3 SILVER 53
- 8.4 GOLD 53
- 8.5 PLATINUM 54
9 U.K. HEALTH INSURANCE MARKET, BY SERVICE PROVIDERS 55
- 9.1 OVERVIEW 56
- 9.2 PUBLIC HEALTH INSURANCE PROVIDERS 57
- 9.3 PRIVATE HEALTH INSURANCE PROVIDERS 57
10 U.K. HEALTH INSURANCE MARKET, BY HEALTH INSURANCE PLANS 58
- 10.1 OVERVIEW 59
- 10.2 POINT OF SERVICE (POS) 60
- 10.3 EXCLUSIVE PROVIDER ORGANIZATION (EPOS) 60
- 10.4 PREFERRED PROVIDER ORGANIZATION (PPO) 61
- 10.5 INDEMNITY HEALTH INSURANCE 61
- 10.6 HEALTH MAINTENANCE ORGANIZATION (HMO) 61
- 10.7 HEALTH SAVINGS ACCOUNT (HSA) 61
- 10.8 QUALIFIED SMALL EMPLOYER HEALTH REIMBURSEMENT ARRANGEMENTS (QSEHRAS) 62
- 10.9 OTHERS 62
11 U.K. HEALTH INSURANCE MARKET, BY DEMOGRAPHICS 63
- 11.1 OVERVIEW 64
- 11.2 ADULTS 65
- 11.3 MINORS 65
- 11.4 SENIOR CITIZENS 65
12 U.K. HEALTH INSURANCE MARKET, BY COVERAGE TYPE 66
- 12.1 OVERVIEW 67
- 12.2 LIFETIME COVERAGE 68
- 12.3 TERM COVERAGE 68
13 U.K. HEALTH INSURANCE MARKET, BY END-USER 69
- 13.1 OVERVIEW 70
- 13.2 CORPORATES 71
- 13.3 INDIVIDUALS 71
- 13.4 OTHERS 72
14 U.K. HEALTH INSURANCE MARKET, BY DISTRIBUTION CHANNEL 73
- 14.1 OVERVIEW 74
- 14.2 DIRECT SALES 75
- 14.3 FINANCIAL INSTITUTIONS 75
- 14.4 E-COMMERCE 76
- 14.5 HOSPITALS 76
- 14.6 CLINICS 76
- 14.7 OTHERS 76
15 U.K. HEALTH INSURANCE MARKET, COMPANY LANDSCAPE 77
- 15.1 COMPANY SHARE ANALYSIS: U.K. 77
16 SWOT ANALYSIS 78
17 COMPANY PROFILE 79
- 17.1 CIGNA 79
- 17.1.1 COMPANY SNAPSHOT 79
- 17.1.2 REVENUE ANALYSIS 80
- 17.1.3 PRODUCT PORTFOLIO 80
- 17.1.4 RECENT UPDATE 81
- 17.2 AVIVA 82
- 17.2.1 COMPANY SNAPSHOT 82
- 17.2.2 REVENUE ANALYSIS 82
- 17.2.3 PRODUCT PORTFOLIO 83
- 17.2.4 RECENT UPDATES 83
- 17.3 ALLIANZ CARE (A SUBSIDIARY OF ALLIANZ) 84
- 17.3.1 COMPANY SNAPSHOT 84
- 17.3.2 REVENUE ANALYSIS 84
- 17.3.3 PRODUCT PORTFOLIO 85
- 17.3.4 RECENT UPDATE 85
- 17.4 AXA 87
- 17.4.1 COMPANY SNAPSHOT 87
- 17.4.2 REVENUE ANALYSIS 87
- 17.4.3 PRODUCT PORTFOLIO 88
- 17.4.4 RECENT UPDATES 88
- 17.5 BUPA 89
- 17.5.1 COMPANY SNAPSHOT 89
- 17.5.2 REVENUE ANALYSIS 89
- 17.5.3 PRODUCT PORTFOLIO 90
- 17.5.4 RECENT UPDATES 90
- 17.6 AMERICAN INTERNATIONAL GROUP, INC. (2021) 92
- 17.6.1 COMPANY SNAPSHOT 92
- 17.6.2 REVENUE ANALYSIS 92
- 17.6.3 PRODUCT PORTFOLIO 93
- 17.6.4 RECENT DEVELOPMENTS 93
- 17.7 EXETER FRIENDLY SOCIETY LIMITED 94
- 17.7.1 COMPANY SNAPSHOT 94
- 17.7.2 PRODUCT PORTFOLIO 94
- 17.7.3 RECENT DEVELOPMENTS 94
- 17.8 FREEDOM HEALTH INSURANCE 95
- 17.8.1 COMPANY SNAPSHOT 95
- 17.8.2 PRODUCT PORTFOLIO 95
- 17.8.3 RECENT DEVELOPMENTS 95
- 17.9 GENERAL AND MEDICAL FINANCE LTD 96
- 17.9.1 COMPANY SNAPSHOT 96
- 17.9.2 PRODUCT PORTFOLIO 96
- 17.9.3 RECENT DEVELOPMENTS 96
- 17.10 PRU LIFE UK 97
- 17.10.1 COMPANY SNAPSHOT 97
- 17.10.2 PRODUCT PORTFOLIO 97
- 17.10.3 RECENT DEVELOPMENTS 97
- 17.11 SAGA (2021) 99
- 17.11.1 COMPANY SNAPSHOT 99
- 17.11.2 REVENUE ANALYSIS 99
- 17.11.3 PRODUCT PORTFOLIO 100
- 17.11.4 RECENT DEVELOPMENTS 100
- 17.12 VITALITY (A SUBSIDIARY OF DISCOVERY LTD) 101
- 17.12.1 COMPANY SNAPSHOT 101
- 17.12.2 REVENUE ANALYSIS 101
- 17.12.3 PRODUCT PORTFOLIO 102
- 17.12.4 RECENT UPDATES 102
18 QUESTIONNAIRE 103
19 RELATED REPORTS 108